Skip to Content
Merck
CN

G7208

Ethylene sulfite

greener alternative

98%

Synonym(s):

1,3,2-Dioxathiolan-2-oxide, Cyclic ethylene sulfite, ES, Glycol sulfite

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C2H4O3S
CAS Number:
Molecular Weight:
108.12
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
223-131-7
Beilstein/REAXYS Number:
1237109
MDL number:
Assay:
98%
Form:
liquid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

98%

form

liquid

greener alternative product characteristics

Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

refractive index

n20/D 1.445 (lit.)

bp

159.1 °C (lit.)

density

1.426 g/mL at 25 °C (lit.)

greener alternative category

SMILES string

O=S1OCCO1

InChI

1S/C2H4O3S/c3-6-4-1-2-5-6/h1-2H2

InChI key

WDXYVJKNSMILOQ-UHFFFAOYSA-N

General description

We are committed to bringing you Greener Alternative Products, which belongs to one of the four categories of greener alternatives. This enabling product has been enhanced for energy efficiency. Click here for more information.


Still not finding the right product?

Explore all of our products under Ethylene sulfite


Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

197.1 °F

flash_point_c

91.7 °C

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Joseph P O'Shea et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 96, 207-216 (2015-07-29)
Novel formulations that overcome the solubility limitations of poorly water soluble drugs (PWSD) are becoming ever more critical to a drug development process inundated with these compounds. There is a clear need for developing bio-enabling formulation approaches to improve oral
Dharmendra K Yadav et al.
AAPS PharmSciTech, 16(4), 855-864 (2015-01-15)
The objective of this study was to develop novel docetaxel phospholipid nanoparticles (NDPNs) for intravenous administration. Modified solvent diffusion-evaporation method was adopted in the NDPN preparation. Central composite design (CCD) was employed in the optimization of the critical formulation factor
Hywel D Williams et al.
Journal of pharmaceutical sciences, 103(6), 1734-1746 (2014-04-18)
The current study determined the extent to which the desorption of lipid-based formulations (LBFs) from a mesoporous magnesium aluminometasilicate (Neusilin®-US2) carrier is governed by drug properties, LBF composition, and LBF-to-adsorbent ratio. A secondary objective was to evaluate the impact of



Global Trade Item Number

SKUGTIN
G7208-25G04061832423319